Latest Regulatory Approvals News

Tabcorp Holdings has agreed to acquire BetMakers Technology Group for approximately $267 million, aiming to accelerate its wagering technology upgrade and expand its global B2B footprint. The deal targets $30 million in cost synergies by Year 2 and expects double-digit EPS accretion by Year 3.

GoldArc Resources has cleared the last regulatory hurdle for its Mt Stirling gold project, enabling development to proceed under a 50/50 profit-share partnership with BML Ventures.

Imricor Medical Systems has ignited its US commercial operations with rapid adoption by top pediatric hospitals, buoyed by FDA pediatric clearances and clinical trial progress.

BPM Minerals has kicked off a record 20,000m reverse circulation drilling campaign at its Forelands Gold Project in Western Australia, targeting a maiden JORC-compliant resource at Beachcomber and preparing for maiden drilling at Bonnie & Clyde.

Sunrise Energy Metals has landed a conditional US$400 million loan commitment from the U.S. Department of War’s Office of Strategic Capital to back its Syerston Scandium Project, while also initiating plans for a U.S. securities listing.

Stavely Minerals has released a comprehensive Scoping Study for its Thursday’s Gossan and Cayley Lode deposits in western Victoria, outlining a 13-year open pit copper-gold-silver operation with strong financial metrics and a 4Mtpa processing plant.

Yari Resources (ASX: YAR) is set to double its Bowen Basin coal resource to over 500 million tonnes through a binding conditional acquisition of the Arcadia Coal Project, backed by a $2.2 million placement.

Iris Cairns Property Trust has secured over 80% of Reef Casino Trust units, making its $3.87 per unit takeover offer unconditional and setting a firm 14 August deadline without extension.

Li-FT Power Ltd. is raising $20 million through a common share offering priced at $2.90 each, primarily to cover care and maintenance costs for its Renard diamond mine option and support corporate activities. The deal includes a 15% over-allotment option and has conditional TSXV approval.

Philips has officially declared compatibility for Imricor’s interventional MR devices with its magnetic resonance systems, enabling commercial clinical use and collaboration at a leading cardiology congress.

Clarity Pharmaceuticals has presented compelling clinical evidence that its investigational 64Cu-SAR-bisPSMA diagnostic and 67Cu-SAR-bisPSMA therapeutic candidates outperform current standards in prostate cancer care, positioning the company for regulatory and commercial milestones.

American Tungsten & Antimony plans to restart and expand the Del Sol Refinery and White Spar Mine in the US, contingent on completing their acquisition. The company is preparing for increased processing capacity and new product lines while engaging with regulators and engineering firms.